CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2

Nature Immunology

Volumn 6, Issue 2, 2005, Pages 152-162

  Tai, Xuguang ^a   Cowan, Michelle ^a   Feigenbaum, Lionel ^b   Singer, Alfred ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR; DNA BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BINDING; FEMALE; GENE EXPRESSION; GENE MAPPING; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE; THYMUS; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD28; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES; THYMUS GLAND;

EID: 13944260538     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1160     Document Type: Article

References (49)

1. Marrack, P. et al. The effect of thymus environment on T cell development and tolerance. Cell 53, 627-634 (1988).
2. Ramsdell, F., Lantz, T. & Fowlkes, B.J. A nondeletional mechanism of thymic self tolerance. Science 246, 1038-1041 (1989).
3. Roberts, J.L., Sharrow, S.O. & Singer, A. Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J. Exp. Med. 171, 935-940 (1990).
4. + T cells: evidence from a lymphopenic T cell model. Immunity 17 425-436 (2002).
5. Walker, L.S. & Abbas, A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2, 11-19 (2002).
6. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
7. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18-32 (2001).
8. + suppressor T cells. Immunol. Rev. 182, 58-67 (2001).
9. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389-400 (2002).
10. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192 303-310 (2000).
11. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
12. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3, 135-142 (2002).
13. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
14. + immunoregulatory T cells. J. Exp. Med. 194, 427-438 (2001).
15. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
16. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
17. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 1057-1061 (2003).
18. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
19. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
20. Kishimoto, H. & Sprent, J. Several different cell surface molecules control negative selection of medullary thymocytes. J. Exp. Med. 190, 65-73 (1999).
21. + thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179, 709-713 (1994).
22. + thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus. J. Exp. Med. 186, 1911-1922 (1997).
23. Sharpe, A.H. & Freeman, G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2, 116-126 (2002).
24. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440 (2000).
25. + regulatory T cells. J. Immunol. 171 3348-3352 (2003).
26. Jenkins, M.K., Taylor, P.S., Norton, S.D. & Urdahl, K.B. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147, 2461-2466 (1991).
27. Boise, L.H. et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3 87-98 (1995).
28. Alegre, M.L., Frauwirth, K.A. & Thompson, C.B. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 1, 220-228 (2001).
29. Oehen, S., Feng, L., Xia, Y., Surh, C.D. & Hedrick, S.M. Antigen compartmentation and T helper cell tolerance induction. J. Exp. Med. 183, 2617-2626 (1996).
30. Pages, F et al. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369, 327-329 (1994).
31. Prasad, K.V. et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA 91, 2834-2838 (1994).
32. Marengere, L.E. et al. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28. J. Immunol. 159, 3220-3229 (1997).
33. Holdorf, A.D. et al. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. Exp. Med. 190, 375-384 (1999).
34. Papiernik, M., de Moraes, M.L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371-378 (1998).
35. Malek, T.R., Yu, A., Vincek, V., Scibelli, P. & Kong, L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17 167-178 (2002).
36. + T cell numbers. J. Immunol. 169, 4850-4860 (2002).
37. Cibotti, R., Punt, J.A., Dash, K.S., Sharrow, S.O. & Singer, A. Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals. Immunity 6, 245-255 (1997).
38. McKean, D.J. et al. Maturation versus death of developing double-positive thymocytes reflects competing effects on Bcl-2 expression and can be regulated by the intensity of CD28 costimulation. J. Immunol. 166, 3468-3475 (2001).
39. + T cell lineages: a new perspective on thymic commitment and selection. Immunity 2, 413-425 (1995).
40. Holdorf, A.D., Lee, K.H., Burack, W.R., Allen, P.M. & Shaw, A.S. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat. Immunol. 3, 259-264 (2002).
41. Viola, A., Schroeder, S., Sakakibara, Y. & Lanzavecchia, A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283, 680-682 (1999).
42. Shahinian, A. et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612 (1993).
43. Okkenhaug, K. et al. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2, 325-332 (2001).
44. Burr, J.S. et al. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J. Immunol. 166, 5331-5335 (2001).
45. Harada, Y. et al. Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo. J. Immunol. 166, 3797-3803 (2001).
46. Andres, P.G. et al. Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. Nat. Immunol. 5, 435-442 (2004).
47. + thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells. Immunity 13, 59-71 (2000).
48. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O. & Korsmeyer, S.J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888 (1991).
49. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341, 746-749 (1989).